Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q77312717)
Watch
English
Bisphosphonates
scientific article published on 01 February 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9741331
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9741331%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Bisphosphonates
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9741331
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9741331%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
author name string
J J Body
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9741331
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9741331%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
publication date
1 February 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9741331
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9741331%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
published in
European Journal of Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9741331
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9741331%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
volume
34
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9741331
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9741331%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9741331
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9741331%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
page(s)
263-269
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9741331
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9741331%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
cites work
Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of bisphosphonates in cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: dose-response relationship and influence of tumour type.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A double-blind, crossover trial of intravenous clodronate in metastatic bone pain
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose intravenous pamidronate for metastatic bone pain
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Palliative pamidronate treatment in patients with bone metastases from breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Advanced breast cancer: use of resources and cost implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clodronate decreases the frequency of skeletal metastases in women with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subgroup and cost-benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Administration of the bisphosphonate ibandronate (BM 21.0955) by intravenous bolus injection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910136-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0959-8049(97)10136-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9741331
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9741331%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
PubMed publication ID
9741331
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9741331
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9741331%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit